𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma

✍ Scribed by Joseph M Parker; Chad K Oh; Craig LaForce; S David Miller; David S Pearlman; Chenxiong Le; Gabriel J Robbie; Wendy I White; Barbara White; Nestor A Molfino; the MEDI-528 Clinical Trials Group


Book ID
115016431
Publisher
BioMed Central
Year
2011
Tongue
English
Weight
361 KB
Volume
11
Category
Article
ISSN
1471-2466

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES